A new eugenics startup has hit the scene — and apparently, Elon Musk and his girlfriend, Neuralink director Shivon Zilis, are counted among its clients. That company, Orchid Health, provides tony clients the opportunity to screen their embryos for genetic illnesses starting at around $22,500. While there are a handful of similar genetic prediction firms, Orchid stands out by claiming that it can sequence embryos' entire genome using as few as five cells and predict far more than its competitors— and according to two sources close to the company who spoke to the Washington Post, its services have been used […]